I study the effects of inflammation that drives gut tissue damage and gut microbiome disruption, specifically in the joint-gut axis. Targeting the gut after musculoskeletal injury is a novel therapeutic route to delay/mitigate joint damage that impacts quality of life and activities of daily living.